Case Report

Aortic Valve-in-Valve in a Patient with Infective Endocarditis after COVID-19 Infection: A Case Report

Abstract

Few cases of transcatheter aortic valve implantation (TAVI) following infective endocarditis (IE) have been reported. In this presentation, we discuss the feasibility of TAVI in a degenerated bioprosthetic valve affected by IE.
We examine a rare case involving an elderly man with a degenerated bioprosthetic aortic valve complicated by IE 6 months after a COVID-19 infection. The patient was successfully treated with valve-in-valve intervention following antibiotic therapy for the acute phase of the infection. This resulted in excellent outcomes with no complications in the early postprocedural period and during follow-up visits.
For patients with a destructed bioprosthetic aortic valve due to IE and residual dysfunction after healing, valve-in-valve intervention can be a safe and effective treatment option, particularly for those at high risk for surgery.

1. Albu C, Swaans MJ, ten Berg JM. With the back against the wall: TAVI in a patient with endocarditis. Catheter Cardiovasc Interv 2013;82:E595-597.
2. Brankovic M, Hashemi A, Ansari J, Sharma A. Transcatheter Aortic Valve Replacement for Aortic Valve Infective Endocarditis: A Systematic Review and Call for Action. Cardiol Ther 12:297-306.
3. Anantha-Narayanan M, Reddy YNV, Sundaram V, Murad MH, Erwin PJ, Baddour LM, Schaff HV, Nishimura RA. Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis. Heart 2020;106:1413-1419.
4. De Palo M, Scicchitano P, Malvindi PG, Paparella D. Endocarditis in Patients with Aortic Valve Prosthesis: Comparison between Surgical and Transcatheter Prosthesis. Antibiotics (Basel) 2021;10:50.
5. Santos-Martínez S, Alkhodair A, Nombela-Franco L, Saia F, Muñoz-García AJ, Gutiérrez E, Regueiro A, Jimenez-Diaz VA, Rivero F, Romaguera R, Gómez-Herrero J, Rodriguez-Gabella T, Sathananthan J, Gómez Salvador I, Carrasco-Moraleja M, Rodés-Cabau J, Webb J, López J, San Román JA, Amat-Santos IJ. Transcatheter Aortic Valve Replacement for Residual Lesion of the Aortic Valve Following "Healed" Infective Endocarditis. JACC Cardiovasc Interv 2020;13:1983-1996.
6. Ramos-Martínez A, Fernández-Cruz A, Domínguez F, Forteza A, Cobo M, Sánchez-Romero I, Asensio A. Hospital-acquired infective endocarditis during Covid-19 pandemic. Infect Prev Pract 2020;2:100080.
7. Cosyns B, Motoc A, Arregle F, Habib G. A Plea Not to Forget Infective Endocarditis in COVID-19 Era. JACC Cardiovasc Imaging 2020;13:2470-2471.
8. Shouls G, Bagnall TJ, Pandya B. The "Cooing Pigeon": TAVI for Acute Aortic Regurgitation Secondary to Homograft Degeneration. JACC Case Rep 2020;2:2162-2165.
9. Nguyen C, Cheong AP, Himbert D. Valve-in-valve-in-valve: Treating endocarditis of a transcatheter heart valve. Catheter Cardiovasc Interv 2015;86:E200-204.
Files
IssueVol 19 No 2 (2024): J Teh Univ Heart Ctr QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/jthc.v19i2.16206
Keywords
Aortic valve disease Infective endocarditis Transesophageal echocardiography COVID-19
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Alizadeasl A, Abdi S, Firouzi A, Pouraliakbar H, Sadeghipour P, Azarfarin R, Akbari Parsa N. Aortic Valve-in-Valve in a Patient with Infective Endocarditis after COVID-19 Infection: A Case Report. J Tehran Heart Cent. 2024;19(2):141-146.